Axiom_20Years_Updated logo.jpg
Axiom Exhibiting at Clinical Operations in Oncology Trials West Coast 2022
April 04, 2022 14:38 ET | Axiom Real-Time Metrics Inc
TORONTO, April 04, 2022 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), a premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations,...
Elucida Oncology Logo.jpg
Elucida Oncology’s Lead Clinical Candidate ELU001 to Be Featured in Two Abstracts at the American Association for Cancer Research Annual Meeting
April 04, 2022 10:00 ET | Elucida Oncology, Inc
MONMOUTH JUNCTION, N.J., April 04, 2022 (GLOBE NEWSWIRE) -- Elucida Oncology, a clinical-stage biotechnology company developing the next frontier in targeted cancer therapy, announced today two...
SERB acquires the ri
SERB acquires the rights to Xermelo® outside US and Japan for Carcinoid Syndrome Diarrhoea
April 04, 2022 02:08 ET | BTG Specialty Pharmaceuticals
Paris, April 04, 2022 (GLOBE NEWSWIRE) -- SERB is pleased to announce it has acquired the rights from Ipsen to commercialize Xermelo® (telotristat ethyl) in Europe and other countries outside the US...
Beroni Logo @ Dec 2019.png
Beroni Group Announces Appointment of Dr. John Chiplin to Board of Directors
March 31, 2022 08:25 ET | Beroni Group Limited
NEW YORK and SYDNEY, Australia, March 31, 2022 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise...
PDS Biotech Logo.png
PDS Biotech Provides Business Update and Reports Fourth-Quarter and Full-Year 2021 Financial Results
March 31, 2022 07:00 ET | PDS Biotechnology Corporation
FLORHAM PARK, N.J., March 31, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of molecularly targeted...
Cytovia Therapeutics’ Leadership to Present at Upcoming Conferences
March 29, 2022 10:56 ET | Cytovia Therapeutics
AVENTURA, Fla. and NATICK, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, Inc., a biopharmaceutical company empowering natural killer (NK) cells to fight cancer through stem cell...
Graphical Research.jpg
Ablation Devices Market Trends 2022 | North America, Europe, & APAC Industry Forecasts 2028: Graphical Research
March 29, 2022 05:00 ET | Graphical Research
Pune, India, March 29, 2022 (GLOBE NEWSWIRE) -- The global ablation devices market size is poised to grow at a significant CAGR during the forecast period, as many regions across the world are...
Philips Lung Suite - 01
Philips expands network of clinical partners to set new standard of care for the early diagnosis and treatment of lung cancer
March 28, 2022 05:00 ET | Royal Philips
March 28, 2022 New installs of Philips Lung Suite real-time 3D imaging solution in Belgium, France, Israel, and the UK highlight rapidly-growing global clinical interest in the company’s...
NOVARTIS logo.jpg
Novartis receives positive CHMP opinion for Jakavi® to treat acute and chronic graft-versus-host disease
March 25, 2022 08:09 ET | Novartis Pharma AG
CHMP opinion based on Phase III REACH2 and REACH3 trials that showed Jakavi improved response rates and failure-free survival compared to best available therapy1,2 Graft-versus-host disease (GvHD) is...
NOVARTIS logo.jpg
Novartis receives positive CHMP opinion for Kymriah® CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma in Europe
March 25, 2022 08:03 ET | Novartis Pharma AG
Positive opinion paves way for third indication in Europe for Kymriah, a potentially definitive single infusion CAR-T cell therapy treatment optionCHMP opinion based on Phase II global ELARA trial...